IRIS
BRUNETTI, LEONARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 783
EU - Europa 226
AS - Asia 130
OC - Oceania 2
SA - Sud America 1
Totale 1.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 782
SE - Svezia 98
CN - Cina 87
IT - Italia 60
FR - Francia 27
SG - Singapore 18
IN - India 16
GB - Regno Unito 12
DE - Germania 10
VN - Vietnam 5
CH - Svizzera 3
FI - Finlandia 3
PL - Polonia 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
TH - Thailandia 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
ES - Italia 1
HK - Hong Kong 1
IE - Irlanda 1
MD - Moldavia 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 1.142
Salva come PNG Salva come JPEG
Città #
Chandler 174
Nyköping 96
Fairfield 81
Ashburn 72
Cambridge 51
Houston 33
Seattle 32
Woodbridge 30
Wilmington 28
New York 24
Beijing 22
Lawrence 21
Roxbury 19
Inglewood 16
Marseille 16
Bari 13
Ann Arbor 12
Boydton 9
Des Moines 9
Singapore 9
Milan 8
Guangzhou 7
Paris 6
Shanghai 6
Wuxi 6
Brindisi 5
Dong Ket 5
Naples 5
Patna 5
Bitonto 4
Washington 4
West Jordan 4
Wuhan 4
Dearborn 3
Edinburgh 3
Helsinki 3
Jiaxing 3
Jinhua 3
Los Angeles 3
Princeton 3
San Diego 3
Sannicandro di Bari 3
Shenzhen 3
Warsaw 3
Bhubaneswar 2
Boardman 2
Bokaro 2
Brno 2
Brooklyn 2
Brussels 2
Chandigarh 2
Crispiano 2
Dalian 2
Geneva 2
Giugliano in Campania 2
Kilburn 2
London 2
Lucknow 2
Molfetta 2
Munich 2
Nonthaburi 2
Port Townsend 2
Pune 2
Redwood City 2
Salerno 2
San Francisco 2
Amsterdam 1
Biella 1
Brisbane 1
Canberra 1
Castellana Grotte 1
Chengdu 1
Chicago 1
Chisinau 1
Council Bluffs 1
Dhaka 1
Dublin 1
Easton 1
Falkenstein 1
Guwahati 1
Hounslow 1
Jinan 1
Las Vegas 1
Longyan 1
Madrid 1
Monmouth Junction 1
Nanchang 1
New Bedfont 1
Nuremberg 1
Prescot 1
San Giovanni Bianco 1
San Mateo 1
Shaoxing 1
St Petersburg 1
Toronto 1
Trani 1
Triggiano 1
Vienna 1
Yong'an 1
Zhengzhou 1
Totale 947
Salva come PNG Salva come JPEG
Nome #
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation 96
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease 87
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 75
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 68
Bone-seeking matrix metalloproteinase inhibitors for the treatment of skeletal malignancy 63
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 60
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2‐Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil‐Like Compounds 59
Natural compounds as FAAH inhibitors: preliminary screening and potential developments 58
Identification of Natural Scaffolds as New Multi-Functional Agents for the Treatment of Alzheimer’s Disease 53
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 51
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 46
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 44
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 41
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 39
Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders 35
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 30
Can foods influence the onset and progress of neurodegenerative diseases? 29
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect 29
DEVELOPMENT OF PHENOXYALKYLPIPERIDINES AS HIGH-AFFINITY SIGMA-1 (s1) RECEPTOR LIGANDS WITH POTENT ANTI-AMNESIC ACTIVITY 29
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 27
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 20
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 20
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 18
Peroxisome Proliferator Activated Receptor (PPAR) agonists as Fatty Acid Amide Hydrolase (FAAH) inhibitors: screening and preliminary structure-activity relationships 17
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION 16
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 15
Rivastigmine-based hybrids: a multi-target approach to anti-Alzheimer’s drug design 14
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 13
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF PPARγ 12
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase 11
New phenothiazine-donepezil like hybrids as potential Alzheimer’s disease multitarget drugs with antioxidant properties 9
Novel rivastigmine structure-based hybrids for the potential treatment of Alzheimer’s disease 9
The pivotal role of pyrrolidine ring as multitarget scaffold in neurodegenerative diseases 8
Multitarget 5-HT6R/FAAH/ChE ligands: the future of Alzheimer’s Disease treatment? 7
New rivastigmine-like compounds for the potential treatment of Alzheimer’s disease: a multi-target approach 7
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial Pyruvate Carrier Inhibition and Antidiabetic Properties 5
Novel Rivastigmine-Based Multitarget Hybrids For Potential Treatment of Alzheimer’s Disease: Cu(II) And Fe(III) Chelation Studies 4
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy 4
Role of copper chelating agents: between old applications and new perspectives in neuroscience 4
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease 2
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases 1
Totale 1.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 5 2 9 9 6 6 18 17 18 18 13 5
2020/2021233 30 5 8 47 1 6 42 13 11 45 12 13
2021/2022152 10 6 2 1 0 13 3 5 13 14 26 59
2022/2023418 33 61 36 33 32 52 7 57 68 9 19 11
2023/2024241 14 22 15 12 21 56 12 2 17 23 17 30
2024/202565 65 0 0 0 0 0 0 0 0 0 0 0
Totale 1.235